← Back to Search

Healthy Controls for Heartburn

N/A
Waitlist Available
Led By William Paterson, MD, FRCPC
Research Sponsored by Queen's University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up length at t= 20 minutes - baseline (t=0)
Awards & highlights
No Placebo-Only Group

Summary

Non-cardiac chest pain (NCCP) is a common disorder whose pathophysiology is poorly understood. Some evidence suggests it may be related to sustained esophageal contractions (SECs) of longitudinal smooth muscle. The investigators have previously shown that acid is a trigger for SECs and results in shortening of the esophagus. In this study, the investigators plan to prospectively evaluate esophageal shortening responses to acid in a group of patients with NCCP compared to controls. The investigators will use high resolution esophageal manometry coupled with acid infusion to evaluate shortening. The investigators hypothesize that at least a subset of patients with NCCP will have an exaggerated esophageal shortening response to acid which correlates with symptom production. If our hypothesis proves true, this may lead to a future therapeutic target in the treatment of these patients.

Eligible Conditions
  • Heartburn

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~length at t= 20 minutes - baseline (t=0)
This trial's timeline: 3 weeks for screening, Varies for treatment, and length at t= 20 minutes - baseline (t=0) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Mean Change in Esophageal Length With Acid
Secondary study objectives
Esophageal Length at Maximal Symptom Intensity
Esophageal Length at Symptom Onset
Number of Participants for Whom a Correlation Was Found Between Symptom Onset and Esophageal Shortening

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Non Cardiac Chest Pain PatientsExperimental Treatment1 Intervention
Patients with Chest Pain where Coronary Artery Disease has been formally ruled out are to undergo esophageal manometry testing.
Group II: Healthy ControlsExperimental Treatment1 Intervention
Healthy volunteers without esophageal symptoms are to undergo esophageal manometry testing.

Find a Location

Who is running the clinical trial?

Queen's UniversityLead Sponsor
373 Previous Clinical Trials
124,026 Total Patients Enrolled
William Paterson, MD, FRCPCPrincipal InvestigatorQueen's University
~3 spots leftby Dec 2025